Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-65.03M
Near historical average
Average (9y)
$-62.33M
Historical baseline
Range
High:$-35.87M
Low:$-86.94M
CAGR
+1.5%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-65.03M | +25.2% |
| 2023 | $-86.94M | -142.4% |
| 2022 | $-35.87M | +47.5% |
| 2021 | $-68.34M | -32.3% |
| 2020 | $-51.67M | +27.8% |
| 2019 | $-71.59M | -3.7% |
| 2018 | $-69.04M | -23.6% |
| 2017 | $-55.86M | +9.7% |
| 2016 | $-61.88M | -8.4% |
| 2015 | $-57.07M | - |